miércoles, 7 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 27, 2026

Stocks Falter as Iran War Pushes Energy Prices and Bond Yields Higher

View original at nasdaq.com
Stocks Falter as Iran War Pushes Energy Prices and Bond Yields Higher The S&P 500 Index ($SPX) (SPY) today is down -0.79%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.81%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -1.12%…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The Iran war is disrupting 7.5% of global oil supply

    60% confidence
  • More than 40 energy sites across nine countries in the Middle East have been severely or very severely damaged

    60% confidence
  • Anthropic is testing a new AI model that poses significant cybersecurity risks

    60% confidence
  • Probes target US practices that disrupt global supply chains, covering restrictions on Chinese goods entering US markets, export controls on advanced technology, and limits on bilateral investment in critical sectors

    60% confidence
  • An ECB rate hike in April is not out of the question if there is solid evidence that the Iran war will be lasting and lead to higher inflation

    60% confidence
  • Crude prices could exceed the 2008 record high of close to $150 a barrel if flows through the Strait of Hormuz remain depressed through March

    60% confidence
  • The conflict will cut global oil supply by 8 million bpd this month

    60% confidence
  • Talks with Iran are going 'very well'

    60% confidence
  • Pentagon is considering sending as many as 10,000 additional troops to the Middle East

    60% confidence

Data points we hold from this source

Dow Jones Industrial Average · index value-0.81 percent

Citado en estos reportajes de Via News

Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,986
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,986 hechos verificados con la fuente5,362 documentos fuente archivados
Consulta estos datos → isubstrate.com